The Examination of Relationship Between Self-Efficacy in People With Chronic Low Back Pain

NCT ID: NCT05614674

Last Updated: 2022-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

162 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-30

Study Completion Date

2023-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Self-efficacy is defined as a person's confidence or belief that one can achieve a certain behavioral or cognitive state. Self-efficacy is one of the most important assesment parameters in the self-management model. It is accepted that patients with chronic low back pain with high self-efficacy have a better prognosis than those with low self-efficacy. Due to the complex nature of pain; The relationship between psychological and physical parameters such as pain catastrophy, disability level, depression, physical performance, self-efficacy, pain intensity and fear avoidance arouses curiosity. The aim of this cross-sectional study is to examine the relationship between the level of self-efficacy and sensory, perceptual and motor skills in people with chronic low back pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Self Efficacy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy group

People who don't suffer from low back pain

No interventions assigned to this group

People with low back pain

People who are suffering from low back pain. The pain level has to be at least 3 out of 10 according to Visual Analog Scale (VAS) to be in this group.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being minimum 30 maximum 65 years old
* To be literate
* Accepting to take part in the study


* Being minimum 30 maximum 65 years old
* Minimum 3 score from Visual Analog Scale (VAS)
* Having low back pain for at least 3 months of time
* To be literate
* Accepting to take part in the study

Exclusion Criteria

* Any kind of surgery in low back area
* Surgery story in lower extremities
* Acute low back pain
* Having a neurological disorder
* Having a rheumatological disease which may cause to low back pain
* Having a herniated disc that presses on the sacral nerves
* Being pregnant
Minimum Eligible Age

30 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Suleyman Demirel University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Burak Kara

Physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Burak Kara, Bachelor

Role: PRINCIPAL_INVESTIGATOR

Suleyman Demirel University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Burak Kara, Bachelor

Role: CONTACT

+905453765972

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

72867572-050.01.04-379338

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.